354 related articles for article (PubMed ID: 25681535)
1. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models.
Benson MJ; Thomas NK; Talwar S; Hodson MP; Lynch JW; Woodruff TM; Borges K
Neurobiol Dis; 2015 Apr; 76():87-97. PubMed ID: 25681535
[TBL] [Abstract][Full Text] [Related]
2. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
[TBL] [Abstract][Full Text] [Related]
3. Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models.
Benson MJ; Manzanero S; Borges K
Epilepsia; 2015 Jun; 56(6):895-905. PubMed ID: 25847097
[TBL] [Abstract][Full Text] [Related]
4. The effects of C5aR1 on leukocyte infiltration following pilocarpine-induced status epilepticus.
Benson MJ; Manzanero S; Borges K
Epilepsia; 2017 Apr; 58(4):e54-e58. PubMed ID: 28225153
[TBL] [Abstract][Full Text] [Related]
5. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
Hernandez MX; Jiang S; Cole TA; Chu SH; Fonseca MI; Fang MJ; Hohsfield LA; Torres MD; Green KN; Wetsel RA; Mortazavi A; Tenner AJ
Mol Neurodegener; 2017 Sep; 12(1):66. PubMed ID: 28923083
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant and antiepileptogenic effects of system
Leclercq K; Liefferinge JV; Albertini G; Neveux M; Dardenne S; Mairet-Coello G; Vandenplas C; Deprez T; Chong SA; Foerch P; Bentea E; Sato H; Maher P; Massie A; Smolders I; Kaminski RM
Epilepsia; 2019 Jul; 60(7):1412-1423. PubMed ID: 31179549
[TBL] [Abstract][Full Text] [Related]
7. Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.
Nomaru H; Sakumi K; Katogi A; Ohnishi YN; Kajitani K; Tsuchimoto D; Nestler EJ; Nakabeppu Y
Glia; 2014 Aug; 62(8):1284-98. PubMed ID: 24771617
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice.
Gross A; Benninger F; Madar R; Illouz T; Griffioen K; Steiner I; Offen D; Okun E
Epilepsia; 2017 Apr; 58(4):586-596. PubMed ID: 28166388
[TBL] [Abstract][Full Text] [Related]
9. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.
Carvalho K; Schartz ND; Balderrama-Gutierrez G; Liang HY; Chu SH; Selvan P; Gomez-Arboledas A; Petrisko TJ; Fonseca MI; Mortazavi A; Tenner AJ
J Neuroinflammation; 2022 Jul; 19(1):178. PubMed ID: 35820938
[TBL] [Abstract][Full Text] [Related]
10. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
[TBL] [Abstract][Full Text] [Related]
11. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
12. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
14. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.
Mazarati A; Lu X; Shinmei S; Badie-Mahdavi H; Bartfai T
Neuroscience; 2004; 128(2):431-41. PubMed ID: 15350653
[TBL] [Abstract][Full Text] [Related]
15. The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis.
Choudhry N; Li K; Zhang T; Wu KY; Song Y; Farrar CA; Wang N; Liu CF; Peng Q; Wu W; Sacks SH; Zhou W
Kidney Int; 2016 Sep; 90(3):540-54. PubMed ID: 27370410
[TBL] [Abstract][Full Text] [Related]
16. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
[TBL] [Abstract][Full Text] [Related]
17. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
18. N-Formyl-Methionyl-Leucyl-Phenylalanine Plays a Neuroprotective and Anticonvulsant Role in Status Epilepticus Model.
de Melo IS; Sabino-Silva R; Costa MA; Vaz ER; Anselmo-E-Silva CI; de Paula Soares Mendonça T; Oliveira KB; de Souza FMA; Dos Santos YMO; Pacheco ALD; Freitas-Santos J; Caixeta DC; Goulart LR; de Castro OW
Cell Mol Neurobiol; 2023 Nov; 43(8):4231-4244. PubMed ID: 37742326
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
[TBL] [Abstract][Full Text] [Related]
20. RNA Polymerase 1 Is Transiently Regulated by Seizures and Plays a Role in a Pharmacological Kindling Model of Epilepsy.
Vashishta A; Slomnicki LP; Pietrzak M; Smith SC; Kolikonda M; Naik SP; Parlato R; Hetman M
Mol Neurobiol; 2018 Nov; 55(11):8374-8387. PubMed ID: 29546592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
